Efficacy and cost of high-frequency IGRT in elderly stage III non-small-cell lung cancer patients

High-frequency image-guided radiotherapy (hfIGRT) is ubiquitous but its benefits are unproven. We examined the cost effectiveness of hfIGRT in stage III non-small-cell lung cancer (NSCLC). We selected stage III NSCLC patients [greater than or equal to]66 years old who received definitive radiation t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2021-05, Vol.16 (5), p.e0252053
Hauptverfasser: Heilbroner, Samuel P, Xanthopoulos, Eric P, Buono, Donna, Carrier, Daniel, Durkee, Ben Y, Corradetti, Michael, Wang, Tony J. C, Neugut, Alfred I, Hershman, Dawn L, Cheng, Simon K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!